Turing Pharmaceuticals - Ketamine Program's Unit Acquisition

Turing Pharmaceuticals - Ketamine Program raised a round of funding on May 04, 2016. Investors include Marina Biotech.

Turing Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas, for…

Articles about Turing Pharmaceuticals - Ketamine Program's Unit Acquisition: